| Symbol |
Name |
|
AICDA
|
activation-induced cytidine deaminase
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
AKT1S1
|
AKT1 substrate 1 (proline-rich)
|
|
ATF2
|
activating transcription factor 2
|
|
BAD
|
BCL2-associated agonist of cell death
|
|
BCL10
|
B-cell CLL/lymphoma 10
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL2L11
|
BCL2-like 11 (apoptosis facilitator)
|
|
BCL6
|
B-cell CLL/lymphoma 6
|
|
BMF
|
Bcl2 modifying factor
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BTK
|
Bruton agammaglobulinemia tyrosine kinase
|
|
CARD11
|
caspase recruitment domain family, member 11
|
|
CCND3
|
cyclin D3
|
|
CD19
|
CD19 molecule
|
|
CD79A
|
CD79a molecule, immunoglobulin-associated alpha
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CHEK2
|
checkpoint kinase 2
|
|
CREB1
|
cAMP responsive element binding protein 1
|
|
CREM
|
cAMP responsive element modulator
|
|
DCK
|
deoxycytidine kinase
|
|
EGFR
|
epidermal growth factor receptor
|
|
EIF4EBP1
|
eukaryotic translation initiation factor 4E binding protein 1
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERBB3
|
erb-b2 receptor tyrosine kinase 3
|
|
ETS1
|
v-ets avian erythroblastosis virus E26 oncogene homolog 1
|
|
FCGR2A
|
Fc fragment of IgG, low affinity IIa, receptor (CD32)
|
|
FCGR2B
|
Fc fragment of IgG, low affinity IIb, receptor (CD32)
|
|
FCGR2C
|
Fc fragment of IgG, low affinity IIc, receptor for (CD32) (gene/pseudogene)
|
|
FCRL4
|
Fc receptor-like 4
|
|
GCSAM
|
germinal center-associated, signaling and motility
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
GTF2I
|
general transcription factor IIi
|
|
H2AFX
|
H2A histone family, member X
|
|
H3F3B
|
H3 histone, family 3B (H3.3B)
|
|
HIST1H2BN
|
histone cluster 1, H2bn
|
|
IBTK
|
inhibitor of Bruton agammaglobulinemia tyrosine kinase
|
|
IL6ST
|
interleukin 6 signal transducer
|
|
ITPR1
|
inositol 1,4,5-trisphosphate receptor, type 1
|
|
JUN
|
jun proto-oncogene
|
|
LILRB2
|
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 2
|
|
LIME1
|
Lck interacting transmembrane adaptor 1
|
|
LYN
|
LYN proto-oncogene, Src family tyrosine kinase
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MCTS1
|
malignant T cell amplified sequence 1
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
PARP1
|
poly (ADP-ribose) polymerase 1
|
|
PDPK1
|
3-phosphoinositide dependent protein kinase 1
|
|
PIK3AP1
|
phosphoinositide-3-kinase adaptor protein 1
|
|
PLCG1
|
phospholipase C, gamma 1
|
|
PLCG2
|
phospholipase C, gamma 2 (phosphatidylinositol-specific)
|
|
PTEN
|
phosphatase and tensin homolog
|
|
RASGRP1
|
RAS guanyl releasing protein 1 (calcium and DAG-regulated)
|
|
RASGRP3
|
RAS guanyl releasing protein 3 (calcium and DAG-regulated)
|
|
REL
|
v-rel avian reticuloendotheliosis viral oncogene homolog
|
|
RPS6
|
ribosomal protein S6
|
|
RPS6KB1
|
ribosomal protein S6 kinase, 70kDa, polypeptide 1
|
|
SLAMF1
|
signaling lymphocytic activation molecule family member 1
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STAT6
|
signal transducer and activator of transcription 6, interleukin-4 induced
|
|
SWAP70
|
SWAP switching B-cell complex 70kDa subunit
|
|
SYK
|
spleen tyrosine kinase
|
|
TOB1
|
transducer of ERBB2, 1
|
|
TP53
|
tumor protein p53
|
|
WAS
|
Wiskott-Aldrich syndrome
|
|
XIAP
|
X-linked inhibitor of apoptosis, E3 ubiquitin protein ligase
|
|
ZAP70
|
zeta-chain (TCR) associated protein kinase 70kDa
|